Clinical trial
A Pilot Study of 18F Fluorothymidine (FLT) PET/CT in Lymphoma
NCT00775268 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of 18F Fluorothymidine (FLT) PET/CT in Lymphoma
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- September 29, 2008
- Completion date
- October 23, 2014
- Enrollment
- 31 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.